← Back to headlines
Enlivex Receives Nasdaq Non-Compliance Notice
Enlivex Therapeutics has received a notice from Nasdaq regarding non-compliance due to its share price falling below the $1 minimum requirement.
15 May, 20:16 — 15 May, 20:16
Sources
Showing 1 of 1 sources
